RxDoctor Payments Data

Amanda Willard, APRN

Family · Interlachen, FLNPI 1174305098

Payments from drug & device makers

$411in general payments, 2019–2025

Across 17 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$162
  • Averitas Pharma Inc.$64
  • Acadia Pharmaceuticals Inc$48
  • Lilly USA, LLC$38
  • Insulet Corporation$24
  • GSK$21
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$411100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$411 in reported general payments places this provider in the 50th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$267
Medicare patients
21
Services billed
30

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide122$124,354
EliquisApixaban25$27,643
OzempicSemaglutide22$20,555
JardianceEmpagliflozin24$17,680
TrulicityDulaglutide12$17,404
VraylarCariprazine Hcl12$17,065
FarxigaDapagliflozin Propanediol12$10,129
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$9,085
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,636
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,629
Ventolin HfaAlbuterol Sulfate30$1,768
Albuterol Sulfate HfaAlbuterol Sulfate57$1,727
Omeprazole91$1,440
Gabapentin91$1,382
Atorvastatin Calcium130$862

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$38$141,758134 claims
PfizerEliquis$20$27,64325 claims
Novo NordiskOzempic$15$20,55522 claims
AbbVieVraylar$162$17,06512 claims
GSKTrelegy Ellipta$21$8,63614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 14,618 family providers in Florida.

Other family in Interlachen

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →